1-4 of 4
Francesco Angotzi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of Venetoclax-Based Therapy Followed By Allogeneic Transplantation in Newly Diagnosed and Relapsed/Refractory AML Patients

Matteo Fanin, Davide Lazzarotto, Alessandra Sperotto, Ilaria Tanasi, Matteo Leoncin, Carmela Gurrieri, Carla Fili, Chiara Callegari, Giulia Battaglia, Erica Simeone, Maria Elena Zannier, Luca Tosoni, Gian Luca Morelli, Melissa Bergnach, Michele Gottardi, Edoardo Tamellini, Sara Consolo, Cristina Skert, Francesco Angotzi, Federica Lessi, Mauro Krampera, Francesca Patriarca, Daniela Damiani, Renato Fanin, Mario Tiribelli
Journal: Blood
Blood (2024) 144 (Supplement 1): 6038.
https://doi.org/10.1182/blood-2024-205250
Published: 2024
Journal Articles

Disease Course and Treatment Patterns of Acute Myeloid Leukemia with FLT3 Mutations and Myeloid Sarcoma Reveal High Efficacy of Gilteritinib: A Multicentric Retrospective Study

Francesco Angotzi, Erika Borlenghi, Chiara Sartor, Maria Benedetta Giannini, Giovanni Marconi, Edoardo Tamellini, Mauro Turrini, Federica Loscocco, Ernesta Audisio, Vincenzo Federico, Calogero Vetro, Andrea Visentin, Carmela Gurrieri, Livio Trentin, Felicetto Ferrara, Federica Lessi
Journal: Blood
Blood (2024) 144 (Supplement 1): 1523.
https://doi.org/10.1182/blood-2024-209605
Published: 2024
Journal Articles

Serum Soluble Interleukin-2 Receptor Levels in Hairy Cell Leukemia As a Marker of Tumor Burden with Prognostic Value and As a Tool for Disease Monitoring

Francesco Angotzi, Simone Zoletto, Alessandro Cellini, Chiara Cavaretta, Valeria Ruocco, Ivan Zatta, Laura Forlani, Andrea Serafin, Roberta Bertorelle, Federica Frezzato, Marco Pizzi, Andrea Padoan, Daniela Basso, Giovanni Pizzolo, Livio Trentin, Andrea Visentin
Journal: Blood
Blood (2023) 142 (Supplement 1): 4414.
https://doi.org/10.1182/blood-2023-182675
Published: 2023
Journal Articles

Patients with Chronic Lymphocytic Leukemia Carrying t(14;19) Display a Distinctive Transcriptomic Profile and Adverse Outcome, Which Might be Overcome Continuous Therapy with BTK Inhibitors. an Italian Campus CLL and Eric Study

Andrea Visentin, Enrico Gaffo, Moritz Furstenau, Jennifer A. Woyach, Panagiotis Baliakas, Kerry A Rogers, Cecelia Miller, Claudia Haferlach, Karla Plevova, David Graham Oscier, Zadie Davis, Florence Nguyen Khac, Eleonora Roncaglia, Gian Matteo Rigolin, Anastasia Athanasiadou, Fanny Baran-Marszak, Alberto Valiente, Maria Jose Terol, Pau Abrisqueta, Blanca Espinet, Anna Puiggros, Annalisa Martines, Laura Bonaldi, Francesca Romana Mauro, Lydia Scarfo, Thomas Chatzikonstantinou, Eugen Tausch, Karl Anton Kreuzer, Arnon P. Kater, Francesc Bosch, Michael Doubek, Panayiotis Panayiotidis, Olga Kalashnikova, Federica Frezzato, Monica Facco, Valeria Ruocco, Alessia Buratin, Silvia Orsi, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavarretta, Ivan Zatta, Andrea Serafin, Robin Foa, Barbara F. Eichhorst, Antonio Cuneo, Kostas Stamatopoulos, Paolo Ghia, Stefania Bortoluzzi, Livio Trentin
Journal: Blood
Blood (2023) 142 (Supplement 1): 3275.
https://doi.org/10.1182/blood-2023-174569
Published: 2023